 prognostic significance CA half-life patients ovarian cancer primary chemotherapy surgical cytoreduction patients advanced epithelial ovarian cancer serial serum CA levels surgical cytoreduction multi-agent chemotherapy cisplatin-containing regimens half-life days prolonged overall survival patients disease-free surgical surveillance procedures normalization serum CA levels U/ml days primary operation improved survival